A prediction nomogram for suboptimal debulking surgery in patients with serous ovarian carcinoma based on MRI T1 dual-echo imaging and diffusion-weighted imaging

Insights into Imaging

Table 1 Clinical characteristics of patients with SOC from institution A

Characteristics	Training set, n = 143	Internal validation set, n = 62	p value
Debulking results			0.8045^b
R0	48 (33.57)	19 (30.65)
R1 + R2	95 (66.43)	43 (6935)
Clinical characteristic
Age	53.92 ± 8.76	53.84 ± 10.54	0.956^a
CA-125	923.2 (317.5, 2795.8)	1466.0 (538.5, 2762.8)	0.4374^c
HE-4	362.0 (156.0, 754.0)	422.5 (180.20, 803.8)	0.469^c
LDH	218.0 (169.5, 346.0)	226.50 (171.5, 280.5)	0.8265^c
NLR	3.33 (2.12, 4.77)	3.275 (2.243, 4.827)	0.9265^c
Menopausal status			0.5322^b
Premenopause	45 (31.47)	23 (37.10)
Postmenopause	98 (68.53)	39 (62.90)
FIGO stage			0.657^b
I/II	24 (16.80)	12 (19.40)
III/IV	119 (83.20)	50 (80.60)
ASA			0.293^b
I/II	98 (68.53)	47 (75.81)
III/IV	45 (31.47)	15 (24.19)

SOC Serous ovarian carcinoma, R0 no residual disease, R1 a residual disease with a maximum diameter of ≤ 1 cm; R2 a residual disease with a maximum diameter of > 1 cm; FIGO International Federation of Gynecology and Obstetrics, ASA American Society of Anesthesiologists Classification
^aTwo independent samples Student’s t test
^bChi-squared test
^cWilcoxon’s test